Clinical Trial Update: ONO-4538 Study in Patients With Richter's Transformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ONO-4538 (nivolumab) in patients with Richter's transformation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Richter Transformation

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Richter's Transformation | Phase 2 | Status: RECRUITING